Versor Investments LP Invests $452,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Versor Investments LP purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 19,500 shares of the company's stock, valued at approximately $452,000.

A number of other large investors have also recently made changes to their positions in OPCH. UMB Bank n.a. grew its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the period. International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after acquiring an additional 2,757 shares during the period. Quarry LP grew its position in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after buying an additional 2,628 shares during the period. Blue Trust Inc. grew its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the period. Finally, Venturi Wealth Management LLC grew its position in Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after buying an additional 4,561 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Transactions at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.64% of the company's stock.

Remove Ads

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.17 during trading hours on Thursday, hitting $34.43. 562,104 shares of the stock traded hands, compared to its average volume of 1,757,382. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.85. The company has a market cap of $5.69 billion, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The stock has a 50 day moving average price of $29.38 and a 200 day moving average price of $28.14.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities restated a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, Barrington Research boosted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.